Mirzotamab is a naked IgG1kappa monoclonal antibody targeting the immune checkpoint protein CD276/B7-H3. As the unconjugated form of Mirzotamab clezutoclax, it is a key research tool for investigating B7-H3 function in oncology and immunology through in vitro binding assays and in vivo model studies.
Concentration:
16.85 mg/mL
Molecular Weight:
145 kDa
Purity:
99.45% (May vary between batches)
CAS Number:
[2229859-11-2]
Target:
ADC Antibody,Immunology/Inflammation related,B7
* VAT and and shipping costs not included. Errors and price changes excepted